Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,250.50
+4.50 (0.20%)
Oct 15, 2026, 3:28 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 635.09 billion as of October 15, 2026. It is the 2,914th most valuable company in the world and the 168th biggest in India. Its market cap has increased by 18.90% in one year.
Market Cap
635.09B
Enterprise Value
629.26B
Revenue
177.37B
Global Rank
Country Rank
#168 India
PE Ratio
35.26
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 635.09B, an increase of 55,158.95%. That is a compound annual growth rate of 28.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 635.09B | 10.58% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.13T |
| Laurus Labs | 1.11T |
| Cipla | 1.07T |
| Mankind Pharma | 979.63B |
| Aurobindo Pharma | 969.28B |
| Alkem Laboratories | 627.72B |
| Gland Pharma | 509.42B |
| Ipca Laboratories | 486.91B |